Evidence map›Paper›PMID 21600285›Full record

ArticleNeurobiology of disease2011

Decreased glutathione accelerates neurological deficit and mitochondrial pathology in familial ALS-linked hSOD1(G93A) mice model.

Marcelo R Vargas, Delinda A Johnson, Jeffrey A Johnson

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of disease, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. NR1D1 downregulation in astrocytes induces a phenotype that is detrimental to cocultured motor neurons.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Altered expression of clock and clock-controlled genes in a hSOD1-linked amyotrophic lateral sclerosis mouse model.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Marcelo R VargasDivision of Pharmaceutical Sciences, University of Wisconsin, Madison, WI, USA.
Delinda A Johnson
Jeffrey A Johnson
University of Wisconsin–Madison · US

Funding

Transcriptional Control of Antioxidant Genes in BrainR01ES008089 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI JOHNSON, JEFFREY A · 2002 to 2013
$3.7M
BRAIN GLUTATHIONE S-TRANSFERASES AND NEUROTOXICITYR29ES008089 · NIEHS · UNIVERSITY OF WISCONSIN MADISON · PI JOHNSON, JEFFREY A · 1996 to 2000
$104k
Glutathione in mitochondrial dysfunction and disease progression in ALS-modelsK99ES019186 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI VARGAS, MARCELO R · 2011 to 2011
$90k
NIEHS NIH HHS 1K99ES019186NIEHS NIH HHS ES08089NIEHS NIH HHS K99 ES019186NIEHS NIH HHS R01 ES008089NIEHS NIH HHS R29 ES008089
6 · The paper itself

Abstract

Dominant mutations in Cu/Zn-superoxide dismutase (SOD1) cause familial forms of amyotrophic lateral sclerosis (ALS), a fatal disorder characterized by the progressive loss of motor neurons. To investigate the role of antioxidant defenses in ALS we used knockout mice for the glutamate-cysteine ligase modifier subunit (GCLM-/-), which have a 70-80% reduction in total glutathione. Although GCLM(-/-) mice are viable and fertile, the life span of GCLM(-/-)/hSOD1(G93A) mice decreased in 55% when compared to GCLM(+/+)/hSOD1(G93A) mice. Decreased life span in GCLM(-/-)/hSOD1(G93A) mice was associated to increased oxidative stress, aggravated mitochondrial pathology and increased association of hSOD1 with the mitochondria. Interestingly, when the GCLM(-/-) animals were mated with a different ALS-model which overexpress the experimental mutation hSOD1(H46R/H48Q), no effect was observed in survival of GCLM(-/-)/hSOD1(H46R/H48Q) mice; and little or no mitochondrial pathology was observed. Since a specific disease modifier, such as glutathione deficiency, may affect only certain hSOD1 mutants, these findings contribute to our understanding of the potential difference in the molecular pathways by which different hSOD1 mutants generate disease.

Indexed as

AlanineAmyotrophic Lateral SclerosisAnimalsCells, CulturedCoculture TechniquesDisease Models, AnimalFemaleGlutathioneGlycineMaleMiceMice, Inbred C3HMice, Inbred C57BLMice, KnockoutMice, TransgenicMitochondriaAlanineGlutathioneGlycineSod1 protein, mouseSuperoxide DismutaseSuperoxide Dismutase-1

Identifiers

PMID21600285
PMCPMC3139005
OpenAlexW2090406179

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.